Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vishaka Muhunthan"'
Autor:
Carla Jaeger, Yun Lo, Elena Fulton, Olivia Waltner, Tamer B. Shabaneh, Colin E. Correnti, Oliver Newsom, Ian A. Engstrom, Sami B. Kanaan, Shruti S. Bhise, Jobelle M.C. Peralta, Raymond Ruff, Jason P. Price, Sylvia M. Stull, Andrew R. Stevens, Valentin Voillet, Vishaka Muhunthan, Fionnuala Morrish, James M. Olson, Raphaël Gottardo, Jay Sarthy, Steven Henikoff, Lucas B. Sullivan, Scott N. Furlan, Stanley R. Riddell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72ef94d2d007888398e97ff450e7c929
https://doi.org/10.2139/ssrn.4402129
https://doi.org/10.2139/ssrn.4402129
Autor:
Diana C. Márquez-Garban, Gang Deng, Lorena P. Burton, Gaoyuan Ma, Vishaka Muhunthan, Begonya Comin-Anduix, Gabriela Llarena, Neda Moatamed, Jennifer Murphy, Nalo Hamilton, Daivd Shackelford, Michael E. Jung, Richard J. Pietras
Publikováno v:
Cancer Research. 83:510-510
Triple negative breast cancer (TNBC) occurs in 10-15% of all breast cancer (BC) patients, yet it accounts for almost half of all BC deaths. Women of African ancestry (WAA) are twice as likely as women of European Ancestry (WEA) to be diagnosed with a
Autor:
Megan L. Templeton, Sarah A. Shelby, Richard G. Ivey, Vishaka Muhunthan, Amanda G. Paulovich, Raphael Gottardo, Alexander I. Salter, Sarah L. Veatch, Anusha Rajan, Valentin Voillet, Jeffrey R. Whiteaker, Jacob J. Kennedy, Daniel Sommermeyer, Isabel Leung, Stanley R. Riddell
Publikováno v:
Sci Signal
Chimeric antigen receptor (CAR)-modified T cell therapy is effective in treating lymphomas, leukemias, and multiple myeloma in which the tumor cells have high amounts of target antigen. However, achieving durable remission in patients and extending t
Autor:
Riccardo Sinisi, Elena A. Goun, Nicolas Bonhoure, Vishaka Muhunthan, Aleksey Yevtodiyenko, David B. Shackelford, Pavlo Khodakivskyi, Gihad Abdelhady, Georgy Mikhaylov, Arkadiy A. Bazhin, Anthony E. Jones, Tamara Maric
Publikováno v:
Nature methods
Glucose is a major source of energy for most living organisms, and its aberrant uptake is linked to many pathological conditions. However, our understanding of disease-associated glucose flux is limited owing to the lack of robust tools. To date, pos
Autor:
Valentin Voillet, Carla A. Jaeger-Ruckstuhl, Stanley R. Riddell, Raphael Gottardo, Jennifer M. Specht, Smitha P. S. Pillai, Carolina Berger, Robert H. Pierce, Megha Sarvothama, Sarah M. Garrison, David G. Maloney, Scott N. Furlan, Sylvia Lee, Robert A. Amezquita, A. McGarry Houghton, Shivani Srivastava, Sushma Yechan-Gunja, Kimberly S. Smythe, Christoph Rader, Vishaka Muhunthan
Publikováno v:
Cancer cell. 39(2)
Summary Adoptive therapy using chimeric antigen receptor-modified T cells (CAR-T cells) is effective in hematologic but not epithelial malignancies, which cause the greatest mortality. In breast and lung cancer patients, CAR-T cells targeting the tum
Autor:
Anusha Rajan, Audrey Olshefsky, JayLee M. Johnson, Suzie H. Pun, Colin Correnti, Mesfin M. Gewe, Vishaka Muhunthan, Scott E. Boyken, Stanley R. Riddell, Marc J. Lajoie, Alexander I. Salter, Matthew J. Bick, Alisha Nguyen, David Baker, Jilliane Bruffey, Garreck Lenz, Alfredo Quijano-Rubio, Robert A. Langan
Publikováno v:
Cell Res
Science
Science
Logic at the cell surface A major challenge in medical interventions is to target only diseased cells. Although there are biomarkers characteristic of certain cancers, for example, it is unlikely that a single marker can specify a particular cell typ
Autor:
Vishaka Muhunthan, Begonya Comin-Anduix, Alejandro J. Garcia, Lorena R. Burton, Richard J. Pietras, Gaoyuan Ma, Diana C. Márquez-Garban, Michael E. Jung, Nalo Hamilton, Jennifer M. Murphy, Gang Deng, Cristian D. Yanes, David B. Shackelford
Publikováno v:
Cancer Research. 80:692-692
Triple negative breast cancer (TNBC) occurs in about 15% of breast cancer (BC) patients, yet it accounts for almost 50% of all BC deaths. TNBC is characterized by lack of expression of estrogen, progesterone and HER2 receptors, and it cannot be treat